28171 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)
2021 ◽
Vol 85
(3)
◽
pp. AB177
Keyword(s):
Phase 3
◽